A5101428209- Inflammasome and immune disorders
- interferon and immune responses
- Rheumatoid Arthritis Research and Therapies
- Sarcoidosis and Beryllium Toxicity Research
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Extracellular vesicles in disease
- Ethics in Clinical Research
- Vasculitis and related conditions
- Spondyloarthritis Studies and Treatments
- Infectious Diseases and Tuberculosis
- Liver Diseases and Immunity
- Biosimilars and Bioanalytical Methods
- Cardiovascular Disease and Adiposity
- Microscopic Colitis
- Renal Diseases and Glomerulopathies
- Immune Cell Function and Interaction
- Ferroptosis and cancer prognosis
Izmir Kâtip Çelebi University
2024
Dokuz Eylül University
2013-2018
Ege University
2013
Gaziantep University
2013
Marmara University
2013
Kahramanmaraş Sütçü İmam University
2013
Eskişehir Osmangazi University
2013
Erciyes University
2013
Cukurova University
2013
Hacettepe University
2013
The primary aim of this study was to investigate the prevalence amyloidosis and its related factors in a large number FMF patients.Fifteen centres from different geographical regions Turkey were included study. Detailed demographic medical data based on structured questionnaire records collected. diagnosis histological proof congophilic fibrillar deposits tissue biopsy specimens.There 2246 patients. male/female ratio 0.87 (1049/1197). mean age patients 34.5 years (S.D. 11.9). Peritonitis...
Abstract Aim Familial Mediterranean fever ( FMF ) is the most common autoinflammatory disease. One of characteristics this disease its young age predominance. Nearly 90% patients experience flares during early adult periods. Currently there are limited data for comparison versus late onset and therefore primary aim study was to investigate these two subsets with regard their certain demographic, clinical genetic differences. Methods Early (≤ 20 years, Group 1) (> 2) were identified from...
Background/Objectives: CT-P13 is a biosimilar version of infliximab, monoclonal antibody. In individuals with ankylosing spondylitis (AS), has been shown to be effective and have well-tolerated safety profile. The aim this study was evaluate the long-term drug persistence, safety, efficacy infliximab in patients AS undergoing first-line (1st-line) later (≥2nd-line) treatment clinical practice. Methods: We performed an observational cohort that included based on biological database TURKBIO...
<h3>Background</h3> Several case reports and a few published studies suggest link between Familial Mediterranean Fever (FMF) ankylosing spondylitis (AS). There is very limited data on the clinical features of AS that develops in patients with FMF. <h3>Objectives</h3> To compare demographic association FMF to alone. <h3>Methods</h3> 73 co-existence (AS-FMF) who have been followed at 8 different hospitals were compared 81 consecutive All fulfilled modified New York criteria for additionally...
Familial Mediterranean fever (FMF) is an auto-inflammatory disorder characterized by self limited attacks of and serositis. The disease expression may be different in ethnic groups patients with certain MEFV mutations prone to have more severe a greater probability developing amyloidosis (1). Recently we showed that the only predictor mortality Turkish FMF (2), however clinical subtypes genetic characteristics been never identified previously.
<h3>Background</h3> Familial Mediterranean fever (FMF) is an auto-inflammatory disorder characterized by self limited attacks of and serositis. The disease expression may be different in ethnic groups patients with certain MEFV mutations prone to have more severe a greater probability developing amyloidosis (1). Recently we showed that the only predictor mortality Turkish FMF (2), however clinical subtypes genetic characteristics been never identified previously. <h3>Objectives</h3> aim this...